ATE5049T1 - Chrom-acetylacetonat als diaetetische ergaenzung und pharmazeutisches mittel. - Google Patents

Chrom-acetylacetonat als diaetetische ergaenzung und pharmazeutisches mittel.

Info

Publication number
ATE5049T1
ATE5049T1 AT80200219T AT80200219T ATE5049T1 AT E5049 T1 ATE5049 T1 AT E5049T1 AT 80200219 T AT80200219 T AT 80200219T AT 80200219 T AT80200219 T AT 80200219T AT E5049 T1 ATE5049 T1 AT E5049T1
Authority
AT
Austria
Prior art keywords
pharmaceutical agent
chromium
dietary supplement
chromium acetylacetonate
iii
Prior art date
Application number
AT80200219T
Other languages
English (en)
Inventor
Dennis Patrick Riley
Mark Morgan Anderson
John Truman Rotruck
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Application granted granted Critical
Publication of ATE5049T1 publication Critical patent/ATE5049T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/30—Oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/92—Ketonic chelates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Animal Husbandry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Seeds, Soups, And Other Foods (AREA)
AT80200219T 1979-03-19 1980-03-07 Chrom-acetylacetonat als diaetetische ergaenzung und pharmazeutisches mittel. ATE5049T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2138279A 1979-03-19 1979-03-19
EP80200219A EP0016496B1 (de) 1979-03-19 1980-03-07 Chrom-Acetylacetonat als diätetische Ergänzung und pharmazeutisches Mittel

Publications (1)

Publication Number Publication Date
ATE5049T1 true ATE5049T1 (de) 1983-11-15

Family

ID=21803870

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80200219T ATE5049T1 (de) 1979-03-19 1980-03-07 Chrom-acetylacetonat als diaetetische ergaenzung und pharmazeutisches mittel.

Country Status (10)

Country Link
US (1) US4571391A (de)
EP (1) EP0016496B1 (de)
JP (1) JPS565414A (de)
AT (1) ATE5049T1 (de)
AU (1) AU536196B2 (de)
CA (1) CA1154672A (de)
DE (1) DE3065342D1 (de)
IE (1) IE49650B1 (de)
NZ (1) NZ193164A (de)
ZA (1) ZA801555B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6831881A (en) * 1980-03-31 1981-10-08 Procter & Gamble Company, The Chromium complexes as dietary supplements and pharmaceutical agents
JPS5991861A (ja) * 1982-11-17 1984-05-26 Bikou:Kk 栄養補助食品カルシウム粒
DE3334516A1 (de) * 1983-09-23 1985-04-11 Siemens AG, 1000 Berlin und 8000 München Koppelfeld mit verbindungswegeumkehr, insbesondere fuer fernsprechvermittlungsanlagen
ES2053497T3 (es) * 1986-10-27 1994-08-01 Abbott Lab Formulas nutritivas liquidas para la intolerancia a la glucosa.
IL95220A0 (en) * 1989-07-28 1991-06-10 Thymax Corp Dithiochrome,an insulinbinding molecule,pharmaceutical compositions containing it and methods for extracting it
US5420108A (en) * 1992-09-14 1995-05-30 Shohet; Isaac H. Method of controlling diabetes mellitus
US5631284A (en) * 1993-10-06 1997-05-20 University Of British Columbia Compositions and methods for relaxing smooth muscles
US5811463A (en) * 1993-10-06 1998-09-22 University Of British Columbia Compositions and method for relaxing smooth muscles
WO2003090671A2 (en) * 2002-04-23 2003-11-06 Nutrition 21, Inc. Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance
US7247328B2 (en) * 2002-05-31 2007-07-24 Zinpro Corporation Chromium (III) alpha amino acid complexes
US20060029642A1 (en) 2004-08-03 2006-02-09 Dusan Miljkovic Methods and compositions for improved chromium complexes
US20060083824A1 (en) * 2004-10-20 2006-04-20 Pbm Products Llc Nutritional supplements for glucose intolerant individuals
CA3021932C (en) * 2007-01-31 2020-12-15 Jds Therapeutics, Llc Use of chromium histidinate for treatment of cardiometabolic disorders
ES2579229T3 (es) 2007-03-13 2016-08-08 Jds Therapeutics, Llc Procedimientos y composiciones para la liberación sostenida de cromo
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
US9585898B2 (en) 2008-02-11 2017-03-07 Kenneth O. Russell Method for the reduction of dangerous blood sugar levels
US8932372B2 (en) 2010-02-02 2015-01-13 Celanese International Corporation Integrated process for producing alcohols from a mixed acid feed
AU2012223282B2 (en) 2011-03-01 2017-02-02 Nutrition 21, Llc Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
AU2017217466A1 (en) 2016-02-11 2018-08-23 Nutrition 21, Llc Chromium containing compositions for improving health and fitness

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3134797A (en) * 1960-06-13 1964-05-26 Diamond Alkali Co Preparation of chromium complexes of beta-diketones
US3914410A (en) * 1972-06-13 1975-10-21 Bristol Myers Co Method for preparing sucrose composition containing chromium III salt
US3925433A (en) * 1973-09-10 1975-12-09 Zinpro Corp 1:1 And 2:1 chromium, alpha amino acid complex salts

Also Published As

Publication number Publication date
NZ193164A (en) 1984-12-14
US4571391A (en) 1986-02-18
IE800547L (en) 1980-09-19
ZA801555B (en) 1981-04-29
EP0016496A1 (de) 1980-10-01
CA1154672A (en) 1983-10-04
JPS565414A (en) 1981-01-20
AU5650280A (en) 1980-09-25
AU536196B2 (en) 1984-04-19
IE49650B1 (en) 1985-11-13
EP0016496B1 (de) 1983-10-19
DE3065342D1 (en) 1983-11-24

Similar Documents

Publication Publication Date Title
AU536196B2 (en) Chromium acetylacetonate dietary and pharmaceutical agent
ATE182786T1 (de) Pharmazeutische und/oder kosmetische zubereitung
ATE163849T1 (de) Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure
FI875533A0 (fi) Insulinpreparat foer non-parenteral dosering.
ATE111341T1 (de) Haarkosmetisches präparat.
ATE76306T1 (de) Pharmazeutische loesungen die dimethylsulfoxid enthalten.
ATE94877T1 (de) Piperazinylderivate von purinen und deren isostere als hypoglykaemische wirkstoffe.
HU910979D0 (en) Process for the prodiction of medical preparations with n-neuropeptide-antagonistic effect, containing guanidine derivatives
DK261490D0 (da) New pharmaceutical compound
DE3775331D1 (de) Zusammensetzungen aus vanadium und peroxyd als nachahmungsmittel von insulin.
NO934706D0 (no) Substituerte 4-fenyl-pyridoner og 4-fenyl-2-alkoksypyridiner
ATE32730T1 (de) Indikatormarkierte konjugate von metallothionein und zielsuchenden, biologisch aktiven molekuelen.
KR890004690A (ko) 당뇨병의 치료를 위한 베자피브레이드의 용도
DK0453603T3 (da) Piroxicamholdige farmaceutiske præparater til topisk anvendelse
DE58902582D1 (de) Verwendung der pflanze euphorbia hirta l. und ihrer extrakte sowie ihrer wirkstoffe.
EP0037144A3 (de) Chromkomplexe als Diätzulage und pharmazeutische Mittel
ATE124627T1 (de) Diclofenac-natrium enthaltende pharmazeutische zusammensetzung zur topischen anwendung.
Duhault et al. The pharmacology of S 1702, a new highly effective oral antidiabetic drug with unusual properties. 2. Protective activity of S 1702 on the microvascular system in normal and diabetic rats
ATE2029T1 (de) Diagnostisches mittel und dessen verwendung zum nachweis von urobilinogen.
KR910021244A (ko) 당뇨병성 괴저 치료제
FI843695A7 (fi) Insuliini-johdannaisia, joissa B 30-asema on modifioitu, menetelmiä niiden valmistamiseksi ja niiden käyttö sekä sokeritaudin hoitoon tarkoitettuja lääkeaineita.
DK0402208T3 (da) Sammensætning af vitamin A i fysiologisk dosis og forskellige aktive bestanddele med en terapeutisk aktivitet
DE69008282D1 (de) Kaffeesäure-Derivate, deren Verwendung für medizinische Behandlungen und diese enthaltende pharmazeutische Zusammensetzungen.
Milner The office treatment of minor chemical skin burns
ATE79883T1 (de) Diorganozinn-verbindungen und diese enthaltende mittel mit bakterizider und fungizider wirkung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee